| Literature DB >> 32973683 |
Esmée Botman1, Sanne Treurniet1, Wouter D Lubbers2, Lothar A Schwarte2, Patrick R Schober2, Louise Sabelis3, Edgar J G Peters4, Annelies van Schie5, Ralph de Vries6, Zvi Grunwald7, Bernard J Smilde1, Jakko A Nieuwenhuijzen8, Marieke Visser9, Dimitra Micha10, Nathalie Bravenboer11, J Coen Netelenbos1, Bernd P Teunissen5, Pim de Graaf5, Pieter G H M Raijmakers5, Jan Maerten Smit12, Elisabeth M W Eekhoff1.
Abstract
Fibrodysplasia ossificans progressiva (FOP) is a rare disease in which heterotopic ossification (HO) is formed in muscles, tendons and ligaments. Traumatic events, including surgery, are discouraged as this is known to trigger a flare-up with risk of subsequent HO. Anesthetic management for patients with FOP is challenging. Cervical spine fusion, ankylosis of the temporomandibular joints, thoracic insufficiency syndrome, restrictive chest wall disease, and sensitivity to oral trauma complicate airway management and anesthesia and pose life-threatening risks. We report a patient with FOP suffering from life-threatening antibiotic resistant bacterial infected ulcers of the right lower leg and foot. The anesthetic, surgical and postoperative challenges and considerations are discussed. In addition, the literature on limb surgeries of FOP patients is systemically reviewed. The 44 year-old female patient was scheduled for a through-knee amputation. Airway and pulmonary evaluation elicited severe abnormalities, rendering standard general anesthesia a rather complication-prone approach in this patient. Thus, regional anesthesia, supplemented with intravenous analgosedation and N2O-inhalation were performed in this case. The surgery itself was securely planned to avoid any unnecessary tissue damage. Postoperatively the patient was closely monitored for FOP activity by ultrasound and [18F]PET/CT-scan. One year after surgery, a non-significant amount of HO had formed at the operated site. The systematic review revealed seventeen articles in which thirty-two limb surgeries in FOP patients were described. HO reoccurrence was described in 90% of the cases. Clinical improvement due to improved mobility of the operated joint was noted in 16% of the cases. It should be noted, though, that follow-up time was limited and no or inadequate imaging modalities were used to follow-up in the majority of these cases. To conclude, if medically urgent, limb surgery in FOP is possible even when general anesthesia is not preferred. The procedure should be well-planned, alternative techniques or procedures should be tested prior to surgery and special attention should be paid to the correct positioning of the patient. According to the literature recurrent HO should be expected after surgery of a limb, even though it was limited in the case described.Entities:
Keywords: ACVR1 gene mutation; [18F]NaF PET/CT; fibrodysplasia ossificans progressiva (FOP); heterotopic ossification (HO); surgery
Mesh:
Year: 2020 PMID: 32973683 PMCID: PMC7472799 DOI: 10.3389/fendo.2020.00570
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Figure 1FOP patient with multiple incurable ulcers at the right lower extremity (A). Ulcer located at the right calcaneus. Despite Intensive wound care, custom-made orthopedic shoes and targeted systemic and topical antimicrobial treatment, surgical intervention was unavoidable. Due to an ulcer on the calf (B) and proximal from the knee, a through-knee amputation was thought to be most favorable for adequate healing and to minimize tissue damage.
Figure 2Anesthetic and surgical management of a through-knee amputation in an FOP patient. (A) Two nerve block catheters, i.e., the femoral (F) and the sciatic nerve block catheter (S), which were both already placed and tested at the preoperative day. The picture shows the antero-lateral aspect of the patient's right leg. The femoral nerve block catheter is positioned at the ventral aspect of the leg, whereas the sciatic nerve catheter is positioned at the lateral aspect of the leg. (B) The patient was carefully positioned on the theater table to prevent any tissue damage that might cause FOP disease activity. The positioning was challenging due to ankylosis in the hips and knees, resulting in the position shown in the picture. (C) Surgical procedure was performed carefully to minimize tissue damage that might cause a flare-up. (D) The skin flap and gastrocnemius muscle transposition were designed to opposite each other to prevent overlapping scars and minimize the chance of fistula formation due to expected wound healing issues. Lateral of the stump an area of necrosis developed, but healed with supportive care.
Figure 3Axial Low dose CT-images at the level of the distal femur of a patient prior to and after a through-knee amputation of the right leg. (A) Eight months prior to the surgery. (B) Twelve months after the surgical procedure. Minor HO formed (4cc) on the right side posterior to the lateral femoral condyle (red arrow). FOP, fibrodysplasia ossificans progressiva; HO, heterotopic ossification; CT, computed tomography.
Figure 4Flowchart of the study selection process.
Articles describing HO reoccurrence and/or clinical outcome after surgery of a limb in an FOP patient.
| Benetos et al. ( | 1 | 14 | Y | Shoulder | Unlock joint | Y | U | U | U | - |
| 18 | Y | Hip | Unlock Joint | Y1 | 7 | 12 | Y, improved mobility | Indomethacin 25 mg/3 dd, RT: 7 Gy in 1 fraction | ||
| Colmenares-Bonilla et al. ( | 2 | 11 | Y | Knee | Unlock joint | Y1 | 1 | 60 | N | Corticosteroids 30 mg/kg, Alendronate 10/mg/day |
| Connor et al. ( | 3 | 1 | N | Shoulder | Remove swelling | Y | - | U | N | - |
| 4 | 6 | U | Shoulder | Unlock joint | Y | U | U | N | - | |
| Corfield et al. ( | 5 | 24 | Y | Wrist | Improve position | Y1 | 3 | 3 | Y: functional position | - |
| Duan et al. ( | 6 | 17 | Y | Hip | HO induced claudication | U | U | 24 | Y: no claudication | - |
| Holmsen et al. ( | 7 | 20 | Y | Hips | Unlock joint | Y1 | 2 | 24 | N | EHDP 10 mg/kg/day |
| Jayasundara et al. ( | 8 | 47 | Y | Shoulder | Unlock joint | Y2 | U | U | Y: improved mobility | Bisphosphonates, indomethacin |
| Hip | Unlock joint | Y2 | U | U | N | Bisphosphonates, indomethacin | ||||
| 52 | Hip | HO induced pressure necrosis | U | - | U | N | RT: 26 Gy in 13 fractions | |||
| Kartal et al. ( | 9 | 13 | N | Hip | Unlock joint | Y | 1.5 | 12 | N | - |
| 14 | N | Hip | Unlock joint | Y | 3 | 12 | N | - | ||
| 15 | N | Hip | Unlock joint | Y | U | 12 | N | - | ||
| Smith et al. ( | 10 | 34 | U | Calf | Unlock joint | N1 | - | U | U | EHDP 20 mg/kg/day |
| Elbow | Unlock joint | U | - | U | Y: improved mobility | EHDP 20 mg/kg/day | ||||
| 11 | 16 | U | Foot | Unlock joint | Y | 3 | 3 | U | ||
| 17 | Foot | Unlock joint | Y | U | U | U | ||||
| 18 | Hip | Unlock joint | Y | U | U | U | ||||
| 23 | Foot | Unlock joint | Y1 | 36 | 36 | U | EHDP 20 mg/kg/day | |||
| U | Hip | Unlock joint | Y1 | 7 | 7 | N | EHDP 20 mg/kg/day | |||
| 12 | 17 | U | Hamstring | Unlock joint | Y | U | U | U | Prednisone 7.5 mg/day | |
| 18 | Biceps | Unlock joint | U | - | U | Y: improved mobility | EHDP 20 mg/kg/day | |||
| Hip | Unlock joint | N1 | - | 24 | Y: improved mobility | EHDP 20 mg/kg/day | ||||
| 13 | 21 | U | Hip1 | Unlock joint | Y | 2 | 5 | N | EHDP 20 mg/kg/day | |
| Kocyigit et al. ( | 14 | 15 | N | Elbow | Unlock joint | Y | U | U | N | - |
| Matsuda et al. ( | 15 | 35 | Y | Malleolus | Incurable ulcer | N | - | 8 | N | - |
| Nerubay et al. ( | 16 | 7 | Y | Femur | Fracture | Y | U | 12 | N | - |
| Obamuyide et al. ( | 17 | 11 | N | Axilla | Unlock joint | Y | U | U | N | - |
| Tiwari et al. ( | 18 | 2 | N | Arm | Removal swelling | Y | U | U | N | - |
| Trigui et al. ( | 19 | 25 | Y | Hip | Unlock joint | Y1 | 2 | 24 | Y: functional position | Corticosteroids, bisphosphonates |
| Waller et al. ( | 20 | 23 | Y | Hip | HO induced pain | U | - | U | Y: less discomfort | - |
HO reoccurrence is stated as YES when the article has specifically mentioned the reoccurrence of HO, YES.